No abstract available
MeSH terms
-
Animals
-
Antipsychotic Agents / adverse effects
-
Antipsychotic Agents / pharmacology
-
Antipsychotic Agents / therapeutic use*
-
Cholinergic Agonists / adverse effects
-
Cholinergic Agonists / pharmacology
-
Cholinergic Agonists / therapeutic use
-
Disease Models, Animal
-
Dopamine Antagonists / adverse effects
-
Dopamine Antagonists / pharmacology
-
Dopamine Antagonists / therapeutic use
-
Enzyme Inhibitors / adverse effects
-
Enzyme Inhibitors / pharmacology
-
Enzyme Inhibitors / therapeutic use
-
Excitatory Amino Acid Antagonists / adverse effects
-
Excitatory Amino Acid Antagonists / pharmacology
-
Excitatory Amino Acid Antagonists / therapeutic use
-
Humans
-
Mice
-
Mice, Transgenic
-
Nitric Oxide Synthase / antagonists & inhibitors
-
Receptor, Serotonin, 5-HT2A
-
Receptors, AMPA / antagonists & inhibitors
-
Receptors, Dopamine D2 / drug effects
-
Receptors, Dopamine D4
-
Receptors, Metabotropic Glutamate / antagonists & inhibitors
-
Receptors, N-Methyl-D-Aspartate / antagonists & inhibitors
-
Receptors, Neurotensin / agonists
-
Receptors, Serotonin / drug effects
-
Schizophrenia / drug therapy*
-
Schizophrenia / etiology
-
Schizophrenia / metabolism
-
Serotonin Antagonists / adverse effects
-
Serotonin Antagonists / pharmacology
-
Serotonin Antagonists / therapeutic use
Substances
-
Antipsychotic Agents
-
Cholinergic Agonists
-
DRD4 protein, human
-
Dopamine Antagonists
-
Drd4 protein, mouse
-
Enzyme Inhibitors
-
Excitatory Amino Acid Antagonists
-
Receptor, Serotonin, 5-HT2A
-
Receptors, AMPA
-
Receptors, Dopamine D2
-
Receptors, Metabotropic Glutamate
-
Receptors, N-Methyl-D-Aspartate
-
Receptors, Neurotensin
-
Receptors, Serotonin
-
Serotonin Antagonists
-
neurotensin type 1 receptor
-
Receptors, Dopamine D4
-
Nitric Oxide Synthase